Emerging Albumin-Binding Anticancer Drugs for Tumor-Targeted Drug Delivery: Current Understandings and Clinical Translation

Albumin has shown remarkable promise as a natural drug carrier by improving pharmacokinetic (PK) profiles of anticancer drugs for tumor-targeted delivery. The exogenous or endogenous albumin enhances the circulatory half-lives of anticancer drugs and passively target the tumors by the enhanced perme...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Hanhee, Jeon, Seong Ik, Ahn, Cheol-Hee, Shim, Man Kyu, Kim, Kwangmeyung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028280/
https://www.ncbi.nlm.nih.gov/pubmed/35456562
http://dx.doi.org/10.3390/pharmaceutics14040728

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028280/
https://www.ncbi.nlm.nih.gov/pubmed/35456562
http://dx.doi.org/10.3390/pharmaceutics14040728

Ejemplares similares